PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Iritis 1,111 Disease Disease Arthritis Psoriatic 7 1 0.01 -0.93 0.14 0.70
Acetic Acid (Acetic Acid)- FDA 168 Drug Drug Amaryl (Glimepiride)- FDA 7 1 0.03 -0.92 0.14 0.76
CAPG 85 Target Drug Kabiramide C 7 1 0.04 -0.92 0.14 0.79
Avandia (Rosiglitazone Maleate)- FDA 66 Drug Drug Amaryl (Glimepiride)- FDA 7 1 0.05 -0.92 0.14 0.80
Actos (Pioglitazone Hydrochloride)- FDA 38 Drug Drug Amaryl (Glimepiride)- FDA 7 1 0.06 -0.91 0.14 0.82
Cancer 1,053,491 Disease Target AP2M1 7 2 0.00 -0.85 0.29 0.56
Cancer 1,053,491 Disease Target CXCL14/BRAK 7 2 0.00 -0.85 0.29 0.56
Cancer 1,053,491 Disease Drug Amaryl (Glimepiride)- FDA 7 2 0.00 -0.85 0.29 0.56
Infection 766,637 Disease Drug Amphotericin B (Ambisome)- FDA 7 2 0.00 -0.85 0.29 0.56
Carcinoma 433,099 Disease Target AP2M1 7 2 0.00 -0.85 0.29 0.57
Carcinoma 433,099 Disease Drug Aromasin (Exemestane)- FDA 7 2 0.00 -0.85 0.29 0.57
Diabetes 332,602 Disease Disease Peyronies Disease 7 2 0.00 -0.85 0.29 0.58
Androgen Receptor 12,918 Target Drug Avodart (Dutasteride)- FDA 7 2 0.01 -0.85 0.29 0.65
Benign Prostatic Hyperplasia 10,026 Disease Drug Avodart (Dutasteride)- FDA 7 2 0.01 -0.85 0.29 0.66
Acarbose (Precose)- FDA 4 Drug Drug Amaryl (Glimepiride)- FDA 7 1 0.19 -0.80 0.25 0.90
Carcinoma 433,099 Disease Target CXCL14/BRAK 7 3 0.00 -0.76 0.43 0.58
Diabetes 332,602 Disease Drug Amaryl (Glimepiride)- FDA 7 3 0.00 -0.76 0.43 0.59
Stroke 146,992 Disease Drug Abciximab (ReoPro)- FDA 7 3 0.00 -0.76 0.43 0.60
Rheumatoid Arthritis 78,952 Disease Disease Arthritis Psoriatic 7 3 0.00 -0.76 0.43 0.62
Platelet Aggregation 25,460 Disease Drug Abciximab (ReoPro)- FDA 7 3 0.01 -0.76 0.43 0.65
Amphotericin B Injection (Abelcet)- FDA 2 Drug Drug Ambisome (Amphotericin B)- FDA 7 1 0.27 -0.65 0.50 0.90
Amphotericin B Injection (Abelcet)- FDA 2 Drug Drug Amphotericin B (Ambisome)- FDA 7 1 0.27 -0.65 0.50 0.90
Cancer 1,053,491 Disease Drug Avodart (Dutasteride)- FDA 7 4 0.00 -0.65 0.57 0.57
Prostate Cancer 71,064 Disease Drug Avodart (Dutasteride)- FDA 7 4 0.01 -0.65 0.57 0.63
Aspergillosis 9,759 Disease Drug Amphotericin B (Ambisome)- FDA 7 4 0.02 -0.65 0.57 0.68
Arimidex (Anastrozole)- FDA 10 Drug Drug Aromasin (Exemestane)- FDA 7 3 0.36 -0.63 0.43 0.93
Cancer 1,053,491 Disease Drug Aromasin (Exemestane)- FDA 7 6 0.00 -0.38 0.86 0.58
Arthritis 128,324 Disease Disease Arthritis Psoriatic 7 7 0.01 -0.35 1.00 0.63
Ambisome (Amphotericin B)- FDA 7 Drug Drug Amphotericin B (Ambisome)- FDA 7 7 1.00 -0.12 1.00 1.00
Cancer 1,053,491 Disease Target Glutathione S-Transferase Mu 2 8 1 0.00 -0.94 0.12 0.54
Cancer 1,053,491 Disease Target Exodus-3 8 1 0.00 -0.94 0.12 0.54
Infection 766,637 Disease Target Prostaglandin Reductase 1 8 1 0.00 -0.94 0.12 0.55
Carcinoma 433,099 Disease Drug Dromostanolone 8 1 0.00 -0.94 0.12 0.56
Carcinoma 433,099 Disease Target Prostaglandin Reductase 1 8 1 0.00 -0.94 0.12 0.56
Diabetes 332,602 Disease Drug Alprazolam (Xanax)- FDA 8 1 0.00 -0.94 0.12 0.56
Diabetes 332,602 Disease Target Glutathione S-Transferase Mu 2 8 1 0.00 -0.94 0.12 0.56
Inflammation 252,734 Disease Target Exodus-3 8 1 0.00 -0.94 0.12 0.57
Depression 220,092 Disease Drug Alprazolam (Xanax)- FDA 8 1 0.00 -0.94 0.12 0.57
Breast Cancer 173,695 Disease Target Glutathione S-Transferase Mu 2 8 1 0.00 -0.94 0.12 0.58
Breast Cancer 173,695 Disease Target Exodus-3 8 1 0.00 -0.94 0.12 0.58
Leukemia 162,805 Disease Target Exodus-3 8 1 0.00 -0.94 0.12 0.58
Tuberculosis 146,217 Disease Target Prostaglandin Reductase 1 8 1 0.00 -0.94 0.12 0.58
Collagen 138,882 Target Target Brain (B-type) Natriuretic Protein 8 1 0.00 -0.94 0.12 0.58
Obesity 138,233 Disease Target Glutathione S-Transferase Mu 2 8 1 0.00 -0.94 0.12 0.58
Shock 134,031 Disease Target Prostaglandin Reductase 1 8 1 0.00 -0.94 0.12 0.58
Fracture 111,575 Disease Disease Deficiency Vitamin D 8 1 0.00 -0.94 0.12 0.58
Lung Cancer 91,416 Disease Target CD62L/L-Selectin 8 1 0.00 -0.94 0.12 0.59
Poisoning 53,779 Disease Drug Alprazolam (Xanax)- FDA 8 1 0.00 -0.94 0.12 0.60
Seizure 44,685 Disease Drug Alprazolam (Xanax)- FDA 8 1 0.00 -0.94 0.12 0.60
Proteinuria 28,803 Disease Target Glutathione S-Transferase Mu 2 8 1 0.00 -0.94 0.12 0.61
Cervical Cancer 28,286 Disease Target Aldo-Keto Reductase Family 1 Member C3 8 1 0.00 -0.94 0.12 0.61
CD34 24,598 Target Target Exodus-3 8 1 0.00 -0.94 0.12 0.62
Glomerulonephritis 23,459 Disease Target Glutathione S-Transferase Mu 2 8 1 0.00 -0.94 0.12 0.62
Cardiac Arrest 20,700 Disease Drug Doxaminol 8 1 0.00 -0.94 0.12 0.62
Antithrombin 13,773 Target Target Glutathione S-Transferase Mu 2 8 1 0.00 -0.94 0.12 0.63
Lung Carcinoma 13,423 Disease Target Aldo-Keto Reductase Family 1 Member C3 8 1 0.00 -0.94 0.12 0.63
Major Depressive Disorder 12,517 Disease Drug Alprazolam (Xanax)- FDA 8 1 0.00 -0.94 0.12 0.63
Benign Prostatic Hyperplasia 10,026 Disease Target Aldo-Keto Reductase Family 1 Member C3 8 1 0.00 -0.94 0.12 0.64
Acute Coronary Syndromes 9,133 Disease Target Brain (B-type) Natriuretic Protein 8 1 0.00 -0.94 0.12 0.64
Hypertriglyceridemia 7,877 Disease Drug Dromostanolone 8 1 0.00 -0.94 0.12 0.65
Kidney Diseases 4,651 Disease Target Glutathione S-Transferase Mu 2 8 1 0.01 -0.94 0.12 0.66
CCL2 3,560 Target Target Glutathione S-Transferase Mu 2 8 1 0.01 -0.94 0.12 0.67
CCL21 808 Target Target Exodus-3 8 1 0.01 -0.93 0.12 0.71
CCL19 658 Target Target Exodus-3 8 1 0.01 -0.93 0.12 0.72
Annexin A1 406 Target Target Glutathione S-Transferase Mu 2 8 1 0.02 -0.93 0.12 0.73
AKT3 293 Target Target Glutathione S-Transferase Mu 2 8 1 0.02 -0.93 0.12 0.74
Glutaredoxin-1 142 Target Target Glutathione S-Transferase Mu 2 8 1 0.03 -0.93 0.12 0.77
Avandia (Rosiglitazone Maleate)- FDA 66 Drug Drug Alprazolam (Xanax)- FDA 8 1 0.04 -0.93 0.12 0.80
Carcinoma 433,099 Disease Target Aldo-Keto Reductase Family 1 Member C3 8 2 0.00 -0.87 0.25 0.57
Stroke 146,992 Disease Drug Doxaminol 8 2 0.00 -0.87 0.25 0.59
Shock 134,031 Disease Target Glutathione S-Transferase Mu 2 8 2 0.00 -0.87 0.25 0.60
Anemia 81,663 Disease Drug Dromostanolone 8 2 0.00 -0.87 0.25 0.61
Colon Cancer 30,064 Disease Target Prostaglandin Reductase 1 8 2 0.00 -0.87 0.25 0.63
Aldactone (Spironolactone)- FDA 18 Drug Drug Alprazolam (Xanax)- FDA 8 2 0.17 -0.82 0.25 0.88
Ck-beta-11 4 Target Target Exodus-3 8 1 0.18 -0.81 0.25 0.89
Cancer 1,053,491 Disease Drug Dromostanolone 8 3 0.00 -0.79 0.38 0.56
CD4 112,219 Target Target Exodus-3 8 3 0.00 -0.79 0.38 0.61
Androgen Receptor 12,918 Target Target Aldo-Keto Reductase Family 1 Member C3 8 3 0.01 -0.79 0.38 0.66
Cancer 1,053,491 Disease Target Prostaglandin Reductase 1 8 4 0.00 -0.71 0.50 0.57
Prostate Cancer 71,064 Disease Target Aldo-Keto Reductase Family 1 Member C3 8 4 0.01 -0.71 0.50 0.63
BNP 6,842 Target Target Brain (B-type) Natriuretic Protein 8 4 0.02 -0.71 0.50 0.69
ELC 355 Target Target Exodus-3 8 5 0.09 -0.61 0.62 0.79
Cancer 1,053,491 Disease Target Aldo-Keto Reductase Family 1 Member C3 8 6 0.00 -0.50 0.75 0.58
Dromostanolone Propionate 3 Drug Drug Dromostanolone 8 3 0.61 -0.41 1.00 0.95
Exodus-2 27 Target Target Exodus-3 8 7 0.48 -0.30 0.88 0.92
Infection 766,637 Disease Target CINC-2- alpha 9 1 0.00 -0.94 0.11 0.54
Infection 766,637 Disease Target CXCL4/PF4 9 1 0.00 -0.94 0.11 0.54
Carcinoma 433,099 Disease Target Carbonic Anhydrase 4 9 1 0.00 -0.94 0.11 0.56
Carcinoma 433,099 Disease Target CXCL4/PF4 9 1 0.00 -0.94 0.11 0.56
Diabetes 332,602 Disease Drug Aprotinin (Trasylol)- FDA 9 1 0.00 -0.94 0.11 0.56
Diabetes 332,602 Disease Target CXCL4/PF4 9 1 0.00 -0.94 0.11 0.56
Inflammation 252,734 Disease Target CXCL4/PF4 9 1 0.00 -0.94 0.11 0.57
Breast Cancer 173,695 Disease Drug Doxazolidine 9 1 0.00 -0.94 0.11 0.57
Leukemia 162,805 Disease Drug Doxazolidine 9 1 0.00 -0.94 0.11 0.57
Stroke 146,992 Disease Drug Aprotinin (Trasylol)- FDA 9 1 0.00 -0.94 0.11 0.58
Tuberculosis 146,217 Disease Target Carbonic Anhydrase 4 9 1 0.00 -0.94 0.11 0.58
Collagen 138,882 Target Target CXCL4/PF4 9 1 0.00 -0.94 0.11 0.58
Obesity 138,233 Disease Drug Doxazolidine 9 1 0.00 -0.94 0.11 0.58
Arthritis 128,324 Disease Target CD254 9 1 0.00 -0.94 0.11 0.58
Hemorrhage 100,979 Disease Drug Aprotinin (Trasylol)- FDA 9 1 0.00 -0.94 0.11 0.58